| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.09 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |